# Robert Boyle

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/robert-boyle
Canonical HTML page: https://getbiobrief.com/entity/robert-boyle

## Recent coverage (1 stories)

### $200B 'Gentleman Scientist' Plan May Unleash a Biotech R&D Renaissance
2026-07-23 23:35:06 · Sentiment: Bullish · Impact: 8/10 · Sources: 2

The White House’s proposal to replace institutional grants with $200B in portable fellowships and golden tickets could dramatically reshape biotech R&D. Startups might gain direct access to top-flight researchers, while big pharma could see its steady university pipeline disrupted. For the biopharma sector, the plan is a high-stakes bet on curiosity-driven discovery over managed research.
Full story: https://getbiobrief.com/story/trump-science-overhaul-biotech

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.